Stančiaková, L.; Brisudová, K.; Škorňová, I.; Bolek, T.; Samoš, M.; Biringer, K.; Staško, J.; Sokol, J.
Evaluating Thromboprophylaxis Strategies for High-Risk Pregnancy: A Current Perspective. Pharmaceuticals 2024, 17, 773.
https://doi.org/10.3390/ph17060773
AMA Style
Stančiaková L, Brisudová K, Škorňová I, Bolek T, Samoš M, Biringer K, Staško J, Sokol J.
Evaluating Thromboprophylaxis Strategies for High-Risk Pregnancy: A Current Perspective. Pharmaceuticals. 2024; 17(6):773.
https://doi.org/10.3390/ph17060773
Chicago/Turabian Style
Stančiaková, Lucia, Kristína Brisudová, Ingrid Škorňová, Tomáš Bolek, Matej Samoš, Kamil Biringer, Ján Staško, and Juraj Sokol.
2024. "Evaluating Thromboprophylaxis Strategies for High-Risk Pregnancy: A Current Perspective" Pharmaceuticals 17, no. 6: 773.
https://doi.org/10.3390/ph17060773
APA Style
Stančiaková, L., Brisudová, K., Škorňová, I., Bolek, T., Samoš, M., Biringer, K., Staško, J., & Sokol, J.
(2024). Evaluating Thromboprophylaxis Strategies for High-Risk Pregnancy: A Current Perspective. Pharmaceuticals, 17(6), 773.
https://doi.org/10.3390/ph17060773